Skip to main content

Genome-Wide Analysis of RAS/ERK Signaling Targets

  • Protocol
  • First Online:
ERK Signaling

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1487))

Abstract

Identifying gene expression changes mediated by signaling pathways is necessary to determine mechanisms that cause phenotypic change. Recent advances in next-generation sequencing and informatic pipelines have streamlined the ability for laboratories to create and analyze transcriptomic data. Here, we describe the preparation of samples and transcriptomic analysis in order to determine gene expression programs regulated by RAS/ERK signaling.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cox AD, Der CJ (2010) Ras history: the saga continues. Small GTPases 1:2–27

    Article  PubMed  PubMed Central  Google Scholar 

  2. Downward J (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3:11–22

    Article  CAS  PubMed  Google Scholar 

  3. Fernandez-Medarde A, Santos E (2011) Ras in cancer and developmental diseases. Genes Cancer 2:344–358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Phipps AI, Buchanan DD, Makar KW et al (2013) KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers. Br J Cancer 108:1757–1764

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Meng D, Yuan M, Li X et al (2013) Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis. Lung Cancer 81:1–10

    Article  PubMed  Google Scholar 

  6. Giehl K (2005) Oncogenic Ras in tumour progression and metastasis. Biol Chem 386: 193–205

    CAS  PubMed  Google Scholar 

  7. Plotnik JP, Budka JA, Ferris MW et al (2014) ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells. Nucleic Acids Res 42:11928–11940

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Pollier J, Rombauts S, Goossens A (2013) Analysis of RNA-Seq data with TopHat and Cufflinks for genome-wide expression analysis of jasmonate-treated plants and plant cultures. Methods Mol Biol 1011:305–315

    Article  CAS  PubMed  Google Scholar 

  9. Trapnell C, Roberts A, Goff L et al (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7:562–578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Reimand J, Arak T, Vilo J (2011) g:Profiler—a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res 39(Web Issue):W307–W315

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Langmead B (2010) Aligning short sequencing reads with Bowtie. Curr Protoc Bioinformatics Chapter 11:Unit 11.7

    PubMed  Google Scholar 

  12. Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105–1111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Reimand J, Kull M, Peterson H et al (2007) g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 35(Web Issue): W193–W200

    Article  PubMed  PubMed Central  Google Scholar 

  14. Zeeberg BR, Qin H, Narasimhan S et al (2005) High-throughput GoMiner, an ‘industrial-strength’ integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 6168

    Google Scholar 

  15. Zhao Y, Adjei AA (2014) The clinical development of MEK inhibitors. Nat Rev Clin Oncol 11:385–400

    Article  CAS  PubMed  Google Scholar 

  16. Samatar AA, Poulikakos PI (2014) Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov 13:928–942

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This work was supported by Research Scholar Award RSG-13-215-01-DMC from the American Cancer Society.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter C. Hollenhorst .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this protocol

Cite this protocol

Plotnik, J.P., Hollenhorst, P.C. (2017). Genome-Wide Analysis of RAS/ERK Signaling Targets. In: Jimenez, G. (eds) ERK Signaling. Methods in Molecular Biology, vol 1487. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6424-6_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6424-6_21

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6422-2

  • Online ISBN: 978-1-4939-6424-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics